Identification of cell surface targets through meta-analysis of microarray data1

Neoplasia (United States)

Volumn 14, Issue 7, 2012, Pages 666-669

  Haeberle, Henry ^a   Dudley, Joel T ^a   Liu, Jonathan T C ^a   Butte, Atul J ^a   Contag, Christopher H ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; CONNECTIVE TISSUE GROWTH FACTOR; EPHRIN RECEPTOR A3; FIBRILLIN 2; FRIZZLED PROTEIN; GLYCOPROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LAMININ; PROTHROMBIN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; SEMAPHORIN; THYMOPOIETIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; VILLIN; ZINC FINGER PROTEIN;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; META ANALYSIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 84865627743     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.12634     Document Type: Article

References (24)

1. Tonn J-C, Grossman SA, Rutka JT, and Westphal, M (2006). Neuro-oncology of CNS Tumors. Springer, Berlin, Germany.
2. Liu JT, Mandella MJ, Loewke NO, Haeberle H, Ra H, Piyawattanametha W, Solgaard O, Kino GS, and Contag CH (2010). Micromirror-scanned dual-axis confocal microscope utilizing a gradient-index relay lens for image guidance during brain surgery. J Biomed Opt 15, 026029.
3. Turner JD and Sanai N (2011). A brain tumor stem cell origin for glioblastoma endothelium. World Neurosurg 75, 574-575.
4. Sanai N, Eschbacher J, Hattendorf G, Coons SW, Preul MC, Smith KA, Nakaji P, and Spetzler RF (2011). Intraoperative confocal microscopy for brain tumors: a feasibility analysis in humans. Neurosurgery 68(2), 282-290.
5. Koc K, Anik I, Cabuk B, and Ceylan S (2008). Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation. Br J Neurosurg 22, 99-103.
6. Liao H, Shimaya K, Wang K, Maruyama T, Noguchi M, Muragaki Y, Kobayashi E, Iseki H, and Sakuma I (2008). Combination of intraoperative 5-aminolevulinic acid-induced fluorescence and 3-D MR imaging for guidance of robotic laser ablation for precision neurosurgery. Med Image Comput Comput Assist Interv 11, 373-380.
7. Grill J, Sainte-Rose C, Jouvet A, Gentet JC, Lejars O, Frappaz D, Doz F, Rialland X, Pichon F, Bertozzi AI, et al. (2005). Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol 6, 573-580.
8. Chargari C, Feuvret L, Levy A, Lamproglou I, Assouline A, Hemery C, Ghorbal L, Lopez S, Tep B, G GB, et al. (2010). Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse. Br J Neurosurg 24, 460-467.
9. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, et al. (1999). Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17, 832-845.
10. Nomura Y, Yasumoto S, Yanai F, Akiyoshi H, Inoue T, Nibu K, Tsugu H, Fukushima T, and Hirose S (2009). Survival and late effects on development of patients with infantile brain tumor. Pediatr Int 51, 337-341.
11. Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, et al. (2008). Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3, e3088.
12. Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, et al. (2006). Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24, 1924-1931.
13. Chen R, Li L, and Butte AJ (2007). AILUN: reannotating gene expression data automatically. Nat Methods 4, 879.
14. Breitling R, Armengaud P, Amtmann A, and Herzyk P (2004). Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573, 83-92.
15. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, and Lempicki RA (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3.
16. English SB and Butte AJ (2007). Evaluation and integration of 49 genome-wide experiments and the prediction of previously unknown obesity-related genes. Bioinformatics 23, 2910-2917.
17. Ritty TM, Broekelmann TJ, Werneck CC, and Mecham RP (2003). Fibrillin-1 and -2 contain heparin-binding sites important for matrix deposition and that support cell attachment. Biochem J 375, 425-432.
18. Grass B, Wachtel M, Behnke S, Leuschner I, Niggli FK, and Schafer BW (2009). Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics. Histopathology 54, 873-879.
19. Lal A, Glazer CA, Martinson HM, Friedman HS, Archer GE, Sampson JH, and Riggins GJ (2002). Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res 62, 3335-3339.
20. Dubuisson L, Lepreux S, Bioulac-Sage P, Balabaud C, Costa AM, Rosenbaum J, and Desmouliere A (2001). Expression and cellular localization of fibrillin-1 in normal and pathological human liver. J Hepatol 34, 514-522.
21. Surawska H, Ma PC, and Salgia R (2004). The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 15, 419-433.
22. Stephens P, Edkins S, Davies H, Greenman C, Cox C, Hunter C, Bignell G, Teague J, Smith R, Stevens C, et al. (2005). A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet 37, 590-592.
23. Davies H, Hunter C, Smith R, Stephens P, Greenman C, Bignell G, Teague J, Butler A, Edkins S, Stevens C, et al. (2005). Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 65, 7591-7595.
24. Cheng N, Brantley D, Fang WB, Liu H, Fanslow W, Cerretti DP, Bussell KN, Reith A, Jackson D, and Chen J (2003). Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. Neoplasia 5, 445-456.